{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:34:54Z","timestamp":1773797694885,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd005552","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2007,1,24]],"date-time":"2007-01-24T00:00:00Z","timestamp":1169596800000}}],"reference-count":46,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005552.pub2","type":"journal-article","created":{"date-parts":[[2007,1,25]],"date-time":"2007-01-25T13:35:23Z","timestamp":1169732123000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome"],"prefix":"10.1002","author":[{"given":"Michael F","family":"Costello","sequence":"first","affiliation":[{"name":"School of Women's & Children's Health, Royal Hospital for Women and IVF Australia; Division of Obstetrics & Gynaecology; Barker Street Randwick Sydney Australia NSW 2031"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhushan","family":"Shrestha","sequence":"additional","affiliation":[{"name":"University of New South Wales; School of public health and community medicine; 2\/137A Parramatta Road Concord NSW Australia 2137"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Eden","sequence":"additional","affiliation":[{"name":"Royal Hospital for Women; Sydney Menopause Centre & Natural Therapies Unit; Locked Bag 2000 Randwick NSW Australia 2031"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Johnson","sequence":"additional","affiliation":[{"name":"University of Auckland; Department of Obstetrics & Gynaecology; PO Box 92019 Auckland New Zealand 1003"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa J","family":"Moran","sequence":"additional","affiliation":[{"name":"Monash University; The Jean Hailes Clinical Research Unit, School of Public Health and Preventive Medicine; Locked bag 29, Monash Medical Centre, Clayton Road Clayton Road Clayton Victoria Australia 3168"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,1,24]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD005552.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/humrep\/deh588","article-title":"The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients","volume":"20","author":"Cibula","year":"2005","journal-title":"Human Reproduction"},{"issue":"7","key":"10.1002\/14651858.CD005552.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/humrep\/17.7.1729","article-title":"Clinical, endocrine and metabolic effects of metformin added to ethinyl-estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study","volume":"17","author":"Elter","year":"2002","journal-title":"Human Reproduction"},{"issue":"9","key":"10.1002\/14651858.CD005552.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1210\/jc.2003-030424","article-title":"Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome","volume":"88","author":"Harborne","year":"2003","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"9","key":"10.1002\/14651858.CD005552.pub2-BIB0004|cit4","first-page":"3161","article-title":"Endocrine and metabolic effects of metformin versus ethinyl-estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study","volume":"85","author":"Morin-Papunen","year":"2000","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD005552.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2002-020997","article-title":"Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study","volume":"88","author":"Morin-Papunen","year":"2003","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.1.01840","article-title":"Effects of metformin and ethinyl-estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome","volume":"152","author":"Rautio","year":"2005","journal-title":"European Journal of Endocrinology"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejogrb.2004.06.035","article-title":"Combined use of metformin and ethinyl estradiol-cyproterone acetate in polycystic ovary syndrome","volume":"118","author":"Mitkov","year":"2005","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0008|cit8","unstructured":"American Cancer Society Cancer facts & figures: 2003 American Cancer Society 2003"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"2","key":"10.1002\/14651858.CD005552.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00003081-200306000-00011","article-title":"Insulin sensitizers for polycystic ovary syndrome","volume":"46","author":"Baillargeon","year":"2003","journal-title":"Clinical Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/humupd\/dmi015","article-title":"Insulin-senstizing agents: use in pregnancy and as therapy in polycystic ovary syndrome","volume":"11","author":"Checa","year":"2005","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2265.1990.tb03897.x","article-title":"Effects of luteinizing hormone, insulin, insulin-like growth factor-1 and insulin-like growth factor small binding protein-1 in the polycystic ovary syndrome","volume":"33","author":"Conway","year":"1990","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1001\/jama.1993.03500210049030","article-title":"Should unpublished data be included in meta-analyses? current convictions and controversies","volume":"269","author":"Cook","year":"1993","journal-title":"Journal of American Medical Association"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(02)04554-5","article-title":"A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome","volume":"79","author":"Costello","year":"2003","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0016|cit16","first-page":"127","article-title":"Polycystic Ovary Syndrome: A Management Update","volume":"34","author":"Costello","year":"2005","journal-title":"Australian Family Physician"},{"issue":"2","key":"10.1002\/14651858.CD005552.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0028-2243(91)90092-Y","article-title":"Endometrial carcinoma; ovarian dysfunction--a risk factor in young women","volume":"41","author":"Dahlgren","year":"1991","journal-title":"European Journal of Obstetrics, Gynecology, & Reproductive Biology"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/jc.2002-021528","article-title":"A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills","volume":"88","author":"Diamanti-Kandarakis","year":"2003","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(87)90155-3","article-title":"Publication bias and clinical trials","volume":"8","author":"Dickersin","year":"1987","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-2007-1016376","article-title":"Molecular mechanisms of insulin resistance in the polycystic ovary syndrome","volume":"12","author":"Dunaif","year":"1994","journal-title":"Seminars in Reproductive Endocrinology"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD005552.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1055\/s-2003-43305","article-title":"Pharmacologic treatment of polycystic ovary syndrome","volume":"21","author":"Ehrmann","year":"2003","journal-title":"Seminars in Reproductive Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005552.pub2-BIB0024|cit24","first-page":"124","article-title":"Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women","volume":"77","author":"Escobedo","year":"1991","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"The Rotterdam ESHRE\/ASRM-sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Frank","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD005552.pub2-BIB0027|cit27","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003989.pub2","article-title":"20 mcg versus >20 mcg Estrogen combined oral contraceptives for contraception (Cochrane Review)","author":"Gallo","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1001\/jama.1993.03510210084032","article-title":"Users' Guides to the Medical Literature: II. How to Use an Article About Therapy or Prevention: A. Are the Results of the Study Valid?","volume":"270","author":"Guyatt","year":"1993","journal-title":"Journal of American Medical Association"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/S0140-6736(03)13409-5","article-title":"Polycystic ovary syndrome and endometrial carcinoma","volume":"361","author":"Hardiman","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0015-0282(98)00454-3","article-title":"Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome","volume":"71","author":"Hasegawa","year":"1999","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/oxfordjournals.humrep.a019031","article-title":"Polycystic ovary syndrome - from gynaecological curiosity to multisystem endocrinopathy","volume":"11","author":"Homburg","year":"1996","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-2007-1016324","article-title":"Systematic literature review and meta-analysis","volume":"14","author":"Hughes","year":"1996","journal-title":"Seminars in Reproductive Endocrinology"},{"issue":"18","key":"10.1002\/14651858.CD005552.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2165\/00003495-200363180-00001","article-title":"Metformin: new understandings, new uses","volume":"63","author":"Hundal","year":"2003","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD005552.pub2-BIB0035|cit35","article-title":"Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome (Cochrane Review)","author":"Lord","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0036|cit36","unstructured":"Monthly Index of Medical Specialities (MIMS) Monthly Index of Medical Specialities (Australia) 2005"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0015-0282(01)02963-6","article-title":"Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome","volume":"77","author":"Nestler","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0015-0282(02)03111-4","article-title":"Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus","volume":"77","author":"Ovalle","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.1999.tb07784.x","article-title":"Insulin resistance: a chicken that has come to roost","volume":"892","author":"Reaven","year":"1999","journal-title":"Annuals of the New York Academy of Science"},{"issue":"3","key":"10.1002\/14651858.CD005552.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0008-6363(01)00478-3","article-title":"Hormones, genetic factors, and gender differences in cardiovascular disease","volume":"53","author":"Rossouw","year":"2002","journal-title":"Cardiovascular Research"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJM199608293350909","article-title":"Insulin and the polycystic ovary syndrome","volume":"335","author":"Utiger","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/humupd\/dmi005","article-title":"Combined oral contraceptives in the treatment of polycystic ovary syndrome","volume":"11","author":"Vrbikova","year":"2005","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/humupd\/8.3.231","article-title":"Long-term health consequences of PCOS","volume":"8","author":"Wild","year":"2002","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD005552.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1067\/mob.2002.119180","article-title":"Polycystic ovary syndrome: a risk for coronary artery disease?","volume":"186","author":"Wild","year":"2002","journal-title":"American Journal of Obstetrics & Gynaecology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd005552.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD005552.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:50:54Z","timestamp":1628545854000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD005552.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2007,1,24]]},"references-count":46,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005552.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD005552.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,24]]}}}